Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital is a clinical research site located in Chelsea, Michigan, United States 48118.
Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital has participated in 197 clinical trials with 167 currently active.
Therapeutic areas: Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall, Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8.
Sponsors: SWOG Cancer Research Network, National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group.
Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital has 197 clinical trials on record, with 167 currently active. Their work covers Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall, Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8.
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.